Highly absorptive forms of curcumin were shown to augment anti-PD-1 therapy by inhibiting STAT3 activation in dendritic cells and tumor cells, thereby restoring T-cell stimulatory activity and enhancing antitumor responses [228]. This evidence concerns the gene STAT3 and neoplasm.